Global Pediatric Bladder Treatment Market, By Type (Diurnal Incontinence, Enuresis, Others), Treatment (Urotherapy, Medication, Surgical Reconstruction, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Pediatric Bladder Treatment Market Analysis and Size
The adoption of unhealthy lifestyles, such as drinking cold drinks & exposure to chemicals, drive the pediatric bladder treatment market growth. Furthermore, the increasing occurrence of anxiety and urological diseases in the pediatric population and the higher demand for minimally invasive treatment options worldwide will increase the global pediatric bladder treatment market.
Data Bridge Market Research analyses a growth rate in the global pediatric bladder treatment market in the forecast period 2023-2030. The expected CAGR of the global sinusitis treatment drugs market tends to be around 4.00% in the mentioned forecast period. The market was valued at USD 3.4 billion in 2022 and would grow to USD 4.65 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Pediatric Bladder Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Diurnal Incontinence, Enuresis, Others), Treatment (Urotherapy, Medication, Surgical Reconstruction, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc (U.S.), AstraZeneca (U.K.), Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Mylan N.V. (U.S.), Novartis AG (Switzerland), Lupin (India), Cipla Inc (India), Aurobindo Pharma (India), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Orion Corporation (Finland), TherapeuticsMD, Inc. (U.S.), AbbVie Inc. (U.S.), Bausch Health Companies Inc. (Canada), Amneal Pharmaceuticals LLC. (U.S.), Apotex Inc. (Canada), Aurobindo Pharma (India)
|
|
Market Opportunities
|
|
Market Definition
The pediatric bladder is a type of urological disease that is most common in children under 3 years old. A sudden urge to urinate occurs in the patient. The symptoms of the disease include regular urinary tract infections and a sudden urge to urinate. As per the report, around 17 to 20% of children may face urine incontinence during the day, and a further 6.6% may face problems at night.
Global Pediatric Bladder Treatment Market Dynamics
Drivers
- Increased Incidence of Pediatric Bladder
Pediatric bladder is a prevalent condition. Additionally, it's estimated that this condition affects about 30% of children at age 4, 10% at age 7, 3% at age 12, and 1% at age 18. Thus, it boosts market growth.
- Rising Healthcare Expenditure
The healthcare expenditure includes all testing devices, healthcare services, family planning activities, and emergency kits designated for health. The factors determining the healthcare expenditure of any country are income (per capita GDP), technological progress and variation in medical practice, and health system characteristics. This healthcare expenditure helps organizations and government bodies increase the research activities on bladder treatment drugs, their upcoming clinical trials, and R&D activities. Thus, it boosts market growth.
Opportunities
- Increased Drug Launches
There have been increased drug launches that are helping in expanding the market growth. For instance, in April 2021, Medtronic plc announced approval from the US FDA to proceed with an investigational device exemption (IDE) trial to evaluate its internally developed implantable tibial neuromodulation (TNM) device, which is a therapy designed to provide relief from symptoms of bladder incontinence.
- The rise in Pediatric Population
The rising pediatric population is the main factor driving the market growth. According to surveys, in 2022, there will be 2 billion children worldwide aged 0 to 14 years old. This factor is projected to create opportunities in the forecast period.
Restraints/Challenges
- Side Effects of Bladder Drugs
The side effects associated with these pediatric bladder drugs could limit the growth of the global market over a forecast period. Effects such as rashes, loss of appetite, fever, fatigue, and constipation can hamper the market growth.
- Lack of Skilled Professionals
The lack of healthcare professionals unable to diagnose the condition and treat the same can hamper the market growth. Trained professionals are required for faster identification of the disease and immediate treatment process so that the recovery can be faster.
This global pediatric bladder treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global pediatric bladder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Pediatric Bladder Treatment Market Scope
The global pediatric bladder treatment market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Diurnal Incontinence
- Enuresis
- Others
Treatment
- Urotherapy
- Medication
- Surgical Reconstruction
- Others
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Pediatric Bladder Treatment Market Regional Analysis/Insights
The global pediatric bladder treatment market is analyzed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global pediatric bladder treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing the highest pediatric bladder treatment market growth throughout the forecasted period due to increased government awareness programs and the number of generic drugs.
North America dominates the market due to the presence of key manufacturers of the product, high research and development and healthcare expenditure, and skilled professionals
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Pediatric Bladder Treatment Market Share Analysis
The global pediatric bladder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global pediatric bladder treatment market.
Key players operating in the global pediatric bladder treatment market include:
- Pfizer Inc (U.S.)
- AstraZeneca (U.K.)
- Endo International plc (Ireland)
- Teva Pharmaceutical Industries Ltd (Israel)
- Sun Pharmaceutical Industries Ltd (India)
- Mylan N.V. (U.S.)
- Novartis AG (Switzerland)
- Aurobindo Pharma (India)
- Sanofi (France)
- Takeda Pharmaceutical Company Limited (Japan)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Orion Corporation (Finland)
- TherapeuticsMD, Inc. (U.S.)
- AbbVie Inc. (U.S.)
- AbbVie Inc. (U.S.)
- Bausch Health Companies Inc. (Canada)
- Amneal Pharmaceuticals LLC. (U.S.)
- Apotex Inc. (Canada)
- Aurobindo Pharma (India)
Research Methodology: Global Pediatric Bladder Treatment Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.
SKU-